Cite

HARVARD Citation

    Presley, C. et al. (n.d.). Preclinical evaluation of SMM‐189, a cannabinoid receptor 2‐specific inverse agonist. Pharmacology research & perspectives. 3 (4), p. n/a. [Online]. 
  
Back to record